Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10065


Very little is known about the incidence, onset, time course, and symptomatology of premature menopause induced by breast cancer therapy. No prospective study exists. The purpose of the present study is to identify determinants of treatment-related amenorrhea nad its effect on quality of life in a cohort of youg breast cancer patients.


Inclusion Criteria: - Non-institutional (community dwelling) woman of any race - Between 18-45 years at the first screening visit - Have regular menstrual cycles - Diagnosed with invasive breast cancer stage I, II, III within the previous eight months - Have physician agreement for patient participation Exclusion Criteria: - No menstrual bleeding cycles - Psychiatric or psychologic abnormality precluding the informed consent process or which would decrease compliance - Previous malignancy (excepting basal and squamous skin cancer and stage 0 cervical cancer) - Stage IV breast malignancy - Residency outside United States - No telephone



Primary Contact:

Principal Investigator
Kimberly Van Zee, MD
Memorial Sloan Kettering Cancer Center

Backup Contact:


Location Contact:

New York, New York 10065
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.